# Automated editorial proposal

- Proposal ID: proposal:587aa4669a72b14da88667c6c611aa2e
- Substance: curcumin
- Suggestion type: new-reference
- Source: [Curcumin-Loaded PEGylated Nanoceria Composite Promotes Diabetic Wound Healing by Suppressing Ferroptosis and Modulating the Inflammatory Microenvironment.](https://pubmed.ncbi.nlm.nih.gov/42963200/)
- PMID: 42963200
- DOI: 10.1002/jbm.a.70180
- Published: 2026-11-01
- Journal: not stated

This file is a review proposal. It is not a published BHWiki article and must not be treated as medical guidance.

## Embedded source snapshot

This abstract snapshot is included so an offline reviewer can check abstract-level claims. It is not a substitute for full-text, version, retraction or licensing verification.

### Abstract

> Diabetic wounds are characterized by persistent oxidative stress, chronic inflammation, and impaired angiogenesis, and current therapies remain inadequate. Herein, we developed a curcumin-loaded PEGylated nanoceria composite (CP@nCeO<sub>2</sub>) composed of an ultrasmall nCeO<sub>2</sub> core (5-8 nm) within a PEG/curcumin shell. The nanocomposite exhibited uniform spherical morphology, mixed Ce<sup>3+</sup>/Ce<sup>4+</sup> oxidation states, good colloidal stability, and pH-responsive curcumin release. CP@nCeO<sub>2</sub> retained robust SOD-and CAT-like activities, showed efficient cellular uptake, excellent hemocompatibility, and no significant cytotoxicity at ≤ 75 μg/mL. In HUVECs, CP@nCeO<sub>2</sub> promoted migration, scavenged intracellular and mitochondrial ROS, upregulated VEGF, and suppressed ferroptosis-related markers (GPX4, FSP1, ACSL4) and HMGB1. In STZ-induced diabetic mice, topical CP@nCeO<sub>2</sub> accelerated wound closure, reduced serum CRP and PCT, enhanced re-epithelialization and epidermal thickness, and increased CD31<sup>+</sup> microvessel density. Mechanistically, CP@nCeO<sub>2</sub> elevated GSH, upregulated GPX4 and FSP1, downregulated ACSL4, and shifted cytokines toward an anti-inflammatory profile (increased IL-4/IL-10; decreased IL-1β, IFN-γ, IL-6). Collectively, CP@nCeO<sub>2</sub> integrates the antioxidant activity of nCeO<sub>2</sub> with the anti-inflammatory and pro-angiogenic effects of curcumin, providing a safe and effective topical nanotherapeutic platform for diabetic wound healing by suppressing ferroptosis, reducing oxidative stress, and modulating inflammation.

## Proposed structured change

```json
{
  "title": "Curcumin-Loaded PEGylated Nanoceria Composite Promotes Diabetic Wound Healing by Suppressing Ferroptosis and Modulating the Inflammatory Microenvironment.",
  "intervention": "Curcumin-loaded PEGylated nanoceria composite (CP@nCeO2)",
  "models": [
    "HUVECs",
    "STZ-induced diabetic mice"
  ],
  "topic": "Diabetic wound healing"
}
```

## Model rationale

The abstract reports a study of a curcumin-containing nanocomposite with cellular and diabetic-mouse wound-healing findings relevant to curcumin evidence.

## Verbatim evidence from the abstract

> Herein, we developed a curcumin-loaded PEGylated nanoceria composite (CP@nCeO<sub>2</sub>) composed of an ultrasmall nCeO<sub>2</sub> core (5-8 nm) within a PEG/curcumin shell.

## Human review

- [ ] Open the canonical publication and inspect the strongest permitted full text.
- [ ] Verify article version, retraction/correction state, population, exposure, comparator, outcome and limitations.
- [ ] Verify funding/conflict and reuse rights; remove any unsupported field.
- [ ] Apply changes manually to the appropriate Markdown source; do not edit this proposal into public content.
- [ ] Run `bun run content:validate`, `bun run test`, and the normal publisher before merging.
